ライフサイエンスコーパス: urine albumin

1 ein, lactate dehydrogenase, electrolytes, or urine albumin.

2 tive sample of subjects, the distribution of urine albumin and creatinine concentrations was examined

3 assessment of albuminuria includes measuring urine albumin and creatinine in an untimed spot urine co

4 KA, pH and creatinine levels during DKA, and urine albumin and creatinine measurements were analyzed.

5 spectively, >= 0.4 absolute correlation with urine albumin and serum creatinine, known prognosticator

6 HGF attenuated urine albumin and total protein excretion in diabetic mi

7 Urine albumin changes rapidly within the first 6 hrs fol

8 EXE intervention significantly reduced the urine albumin concentration (UAC) at week 12 and 24 endp

9 Urine albumin concentrations increased in all salsalate

10 Mean urine albumin concentrations were not significantly diff

11 blacks (NHB) and Mexican Americans, whereas urine albumin concentrations were significantly higher i

12 ants and baseline information about eGFR and urine albumin concentrations.

13 icant reductions in cellular infiltrates and urine albumin, consistent with protection from kidney da

14 ed hypertension (P < 0.001), the increase of urine albumin creatinine ratio (P < 0.01), the fall in g

15 orrelation between serum level of PAI-1 with urine albumin creatinine ratio (UACR) (r = 0.501, p = 0.

16 re considered to have an abnormally elevated urine albumin creatinine ratio if the value was >/=17 mg

17 ell as the threshold reference value for the urine albumin creatinine ratio in the adult intensive ca

18 duration, haemoglobin A1c (HbA1c) levels and urine albumin creatinine ratio.

19 igh CV risk (history of vascular disease and urine-albumin creatinine ratio [UACR] >200 mg/g), and hi

20 The prevalence of microalbuminuria (urine/albumin creatinine ratio 30- 300 mg/g) was 37%, an

21 ng both an eGFR under 60 ml/min/1.73m(2) and urine/albumin creatinine ratio over 300 mg/g (5.56, 1.57

22 was 37%, and prevalence of macroalbuminuria (urine/albumin creatinine ratio over 300 mg/g) was 3%.

23 n rate was 77.9 mL/(min 1.73 m(2)), and mean urine/albumin creatinine ratio was 88.6 mg/g.

24 6 (62%) had eGFR <60 ml/min per 1.73 m(2) or urine albumin-creatinine ratio >30 mg/g at discharge.

25 The use of ACE-I or ARB in participants with urine albumin-creatinine ratio >300 mg/g or diabetes was

26 ned as eGFR <60 mL.min(-1).1.73 m(-2) and/or urine albumin-creatinine ratio >300 mg/g) at baseline.

27 model was developed to estimate albuminuria (urine albumin-creatinine ratio >=30 mg/g).

28 <20 vs. >=20 mL/min/1.73 m(2)), albuminuria (urine albumin-creatinine ratio <300 vs. >=300 mg/g), and

29 0, >/=90 mL.min(-1).1.73 m(-2)) and baseline urine albumin-creatinine ratio (>300, 30-</=300, <30 mg/

30 Urine albumin-creatinine ratio (ACR) was measured on ICU

31 % CI 0.94 to 4.86; P = 0.004), a decrease in urine albumin-creatinine ratio (ETD 24 weeks, -25.0%, 95

32 covariates, including for baseline eGFR and urine albumin-creatinine ratio (UACR) in longitudinal an

33 serum creatinine, estimated GFR (eGFR), and urine albumin-creatinine ratio (UACR) in search of genet

34 identified 5,968 with available preoperative urine albumin-creatinine ratio (UACR) measurements.

35 ns that adjusted for known risk factors, the urine albumin-creatinine ratio (UACR) was a significant

36 measured using spot urine albumin (SUA) and urine albumin-creatinine ratio (uACR).

37 ere consistent across categories of eGFR and urine albumin-creatinine ratio at baseline and across th

38 urine metabolite associations with eGFR and urine albumin-creatinine ratio in an older community-bas

39 ration rate less than 60 mL/min/1.73 m2 or a urine albumin-creatinine ratio of 30 mg/g or higher for

40 R of at least 60 mL/min/1.73 m2 and a 1-time urine albumin-creatinine ratio of at least 30 mg/g.

41 in the simvastatin-treated group, as was the urine albumin-creatinine ratio on day 7 postsurgery.

42 KIM-1), urine biomarkers (EGF/creatinine and urine albumin-creatinine ratio), and eGFR identified fou

43 seline brachial artery diameter (PAI-1, CRP, urine albumin-creatinine ratio), baseline mean flow (N-A

44 ive protein [CRP]), and target organ damage (urine albumin-creatinine ratio).

45 reactive hyperemia (BNP, PAI-1, CRP, renin, urine albumin-creatinine ratio).

46 line estimated glomerular filtration rate or urine albumin-creatinine ratio, or prerandomization left

47 igher serum potassium, lower eGFR, increased urine albumin-creatinine ratio, younger age, female sex,

48 igher serum potassium, lower eGFR, increased urine albumin-creatinine ratio, younger age, female sex,

49 ducts and systemic endothelial injury by the urine albumin-creatinine ratio.

50 We measured serial spot urine albumin-creatinine ratios in 104 critically ill pa

51 oth estimated glomerular filtration rate and urine-albumin-creatinine ratio to stratify risk more com

52 L/min/1.73 m, P=0.21) and albumin excretion (urine albumin/ creatinine 9.76+/-23.6 mg/g vs. 5.91+/-11

53 filtration rate <60 mL/min per 1.73 m(2) or urine albumin/creatinine >30 mg/g) and available echocar

54 s (p = 0.002), MS (p = 0.003) and higher log urine albumin/creatinine (p = 0.005).

55 1.3 vs. 1.0+/-1.0 mg/dl, p<0.001) and higher urine albumin/creatinine levels (3.6+/-2.3 vs. 3.3+/-2.0

56 ecline >=1 ml/min per 1.73 m(2) per year, or urine albumin/creatinine ratio >=30 mg/g.

57 ) at a 1992-1996 research clinic visit, when urine albumin/creatinine ratio (ACR) was measured in spo

58 dex (BMI), glomerular filtration rate (GFR), urine albumin/creatinine ratio (ACR), hypertension, majo

59 idence of CKD events and changes in eGFR and urine albumin/creatinine ratio (UACR) in participants ra

60 raacetic acid clearance) was associated with urine albumin/creatinine ratio (UACR) post-HTx in a subg

61 ey failure; 2) eGFR slope; and 3) changes in urine albumin/creatinine ratio (UACR).

62 rotein cholesterol, creatinine, glucose, and urine albumin/creatinine ratio as standard risk factors,

63 mplete blood count, serum creatinine level), urine albumin/creatinine ratio measure, and a measure of

64 The urine albumin/creatinine ratio was measured twice weekly

65 in, lower baseline eGFR, and higher baseline urine albumin/creatinine ratio.

66 In the final model, urine albumin/creatinine was the variable with the highe

67 methods, we identified a biomarker panel of urine albumin/creatinine, urine EGF/creatinine, plasma K

68 effect was more pronounced in patients with urine albumin:creatinine ratio >=1000 mg/g, for whom the

69 participants of the JHS, aged 21-84 y, with urine albumin:creatinine ratio < 30 mg/g, and eGFR >= 60

70 sterol, smoking, and medications that affect urine albumin:creatinine ratio (ACR).

71 imated glomerular filtration rate (eGFR) and urine albumin:creatinine ratio (UACR) in pooled patient-

72 ly grade 1-2 toxicities, including increased urine albumin:creatinine ratio (UACR), proteinuria, peri

73 ATP6AP2 knockout significantly increased urine albumin:creatinine ratio in both ND and HFD fed mi

74 incident CKD, albuminuria (defined as a spot urine albumin:creatinine ratio of >30 mg/g or albumin ex

75 FR, 31.7 ml per minute per 1.73 m(2); median urine albumin:creatinine ratio, 716.9; mean serum urate

76 C concentrations, and microalbuminuria using urine albumin:creatinine ratios.

77 eduction with once-daily diltiazem decreased urine albumin excretion (2967 +/- 784 mg/d at baseline c

78 =192) and albumin-creatinine ratio and 24-hr urine albumin excretion (n=189) in stable renal transpla

79 tion, specifically serum uric acid (SUA) and urine albumin excretion (UAE), and that high sodium inta

80 Elevated urine albumin excretion (UAER) is a modifiable risk fact

81 s admixture to identify associations between urine albumin excretion (urine albumin-to-creatinine rat

82 us studies have found an association between urine albumin excretion and Amerindian ancestry in Hispa

83 assessment of GFR in addition to monitoring urine albumin excretion and funduscopic changes to ensur

84 eated diabetic mice (P < 0.04) and had lower urine albumin excretion at 10 weeks than VEH-treated dia

85 24 hr urine albumin excretion correlated highly with decreasin

86 ecific variants influencing the variation of urine albumin excretion in Hispanics/Latinos.

87 Increased urine albumin excretion is highly prevalent in Hispanics

88 There was no detectable increase in the urine albumin excretion of Ptpro(-/-) mice.

89 Macroalbuminuria, defined as urine albumin excretion rate (AER)>/=300 mg/d, has long

90 ted from podocytes exhibited an elevation in urine albumin excretion that was accompanied by increase

91 Urine albumin excretion was significantly increased in 3

92 wever, the independent graded association of urine albumin excretion with AKI is unknown.

93 nth-old mice revealed a 1.7-fold increase in urine albumin excretion, accelerated glomerulosclerosis,

94 ng to estimated glomerular filtration rates, urine albumin excretion, and diagnoses from medical reco

95 ment of glomerular filtration rate (GFR) and urine albumin excretion, and kidney injury was evaluated

96 t of diabetic nephropathy with elevations in urine albumin excretion, glomerular and renal hypertroph

97 Albuminuria-increased urine albumin excretion-is associated with cardiovascula

98 sociation of urinary albumin excretion (spot urine albumin indexed to creatinine [UACR]) and the inci

99 ld G6PD-deficient mice (17-20 mo) had higher urine albumin levels and also had evidence for increased

100 children with type 1 diabetes with 1 or more urine albumin levels measured during routine diabetes ca

101 Serial urine albumin measurement may provide a means of monitor

102 greater albuminuria (422 versus 158 micro g urine albumin/mg urine creatinine; P = 0.01).

103 -2.28+/-0.85 ml/min per SD, P=0.008) but not urine albumin (P=0.09).

104 y, and microalbuminuria, measured using spot urine albumin (SUA) and urine albumin-creatinine ratio (

105 m creatinine to estimate kidney function and urine albumin to assess for kidney and endothelial damag

106 type 2 diabetes and chronic kidney disease (urine albumin to creatine ratio, 30-5000 mg/g, estimated

107 fined as diabetes with albuminuria (ratio of urine albumin to creatinine >/=30 mg/g), impaired glomer

108 cts underwent uric acid, iothalamte GFR, and urine albumin to creatinine (ACR) measurements annually

109 lf-reported hypertension), microalbuminuria (urine albumin to creatinine ratio >30 mg/g), and chronic

110 mated from calibrated serum creatinine, spot urine albumin to creatinine ratio (ACR), age, gender, an

111 c for ESRD but is poorly captured by eGFR or urine albumin to creatinine ratio (ACR).

112 ere 2.38 (95% CI, 1.03-4.29) in those with a urine albumin to creatinine ratio (UACR) less than 300 m

113 R) of 30 to less than 90 mL/min/1.73 m(2), a urine albumin to creatinine ratio (UACR) of 200 to less

114 ne if either eGFR under 60mL/min/1.73m(2) or urine albumin to creatinine ratio 3 mg/mmol or more.

115 lar filtration rate < 60 mL/min/1.73 m(2) or urine albumin to creatinine ratio 3 mg/mmol) were exclud

116 [eGFR] < 60 mL/min/1.73 m2) and albuminuria (urine albumin to creatinine ratio [uACR]) > 30 mg/g).

117 In diabetic mice, PRR knockdown decreased urine albumin to creatinine ratio and the renal expressi

118 ate of less than 45 mL/min/1.73 m2, and/or a urine albumin to creatinine ratio of greater than 30 mg/

119 and December 31, 2019, and had an available urine albumin to creatinine ratio within 90 days of a se

120 Spot urine protein to creatinine ratio, spot urine albumin to creatinine ratio, creatinine clearance,

121 etabolite associations within strata of age, urine albumin to creatinine ratio, diabetes and Hispanic

122 imated glomerular filtration rate and higher urine albumin to creatinine ratios were associated with

123 ith diabetes, hypertension, and albuminuria (urine albumin-to-creatinine ratio > or =300 mg/g) who al

124 ) <60 ml/min per 1.73 m(2); we defined MA as urine albumin-to-creatinine ratio >/=25 (women) or 17 (m

125 Albuminuria (urine albumin-to-creatinine ratio >/=30 mg/g), macroalbu

126 atinine ratio >/=30 mg/g), macroalbuminuria (urine albumin-to-creatinine ratio >/=300 mg/g), reduced

127 CKD (eGFR<60 ml/min per 1.73 m(2) [n=832] or urine albumin-to-creatinine ratio >30 mg/g [n=577]).

128 ion rate < 60 ml/min/1.73 m(2) and/or random urine albumin-to-creatinine ratio >= 30 mg/g).

129 etes and albuminuric chronic kidney disease (urine albumin-to-creatinine ratio >=30 to <300 mg/g and

130 te >=25 to <=90 mL per min per 1.73 m(2), or urine albumin-to-creatinine ratio >=300 to <=5000 mg/g a

131 ar filtration rate < or >=60 mL/min/1.73 m2, urine albumin-to-creatinine ratio < or >=300 mg/g, or Ki

132 Urine albumin-to-creatinine ratio (ACR) and protein-to-c

133 In type 1 diabetes, changes in the GFR and urine albumin-to-creatinine ratio (ACR) are related to c

134 imated glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio (ACR) at baseline.

135 The effect of hydroxyurea (HU) on urine albumin-to-creatinine ratio (ACR) is unclear and s

136 (730,577 person-years) from 14 studies with urine albumin-to-creatinine ratio (ACR) measurements and

137 change in albuminuria, measured as change in urine albumin-to-creatinine ratio (ACR) or urine protein

138 ntify associations of creatinine-based eGFR, urine albumin-to-creatinine ratio (ACR), and dipstick pr

139 ion (KFRE) uses the 4 variables of age, sex, urine albumin-to-creatinine ratio (ACR), and estimated g

140 Diabetes increased blood glucose, urine albumin-to-creatinine ratio (ACR), kidney patholog

141 mean arterial pressure, HbA1c, GFR, and the urine albumin-to-creatinine ratio (ACR).

142 15 to <30, or <15 ml/min per 1.73 m(2)) and urine albumin-to-creatinine ratio (ACR; >300, 30-300, or

143 We also identified 2 known loci for urine albumin-to-creatinine ratio (BCL2L11 rs116907128,

144 r of added kidney measures was cysC-eGFR and urine albumin-to-creatinine ratio (DeltaC=0.019 [95% CI,

145 inor allele frequency=0.01, P=1.6x10(-8)) or urine albumin-to-creatinine ratio (rs527493184 at ZBTB16

146 d GFR (eGFR) <60 ml/min per 1.73 m(2) and/or urine albumin-to-creatinine ratio (UACR) >/= 3.5 mg/mmol

147 ension, we examined the relationship between urine albumin-to-creatinine ratio (UACR) and cardiac mec

148 included change from baseline to week 72 for urine albumin-to-creatinine ratio (UACR) and eGFR.

149 Dapagliflozin reduces the urine albumin-to-creatinine ratio (UACR) and estimated g

150 e complementary prognostic value of baseline urine albumin-to-creatinine ratio (uACR) and plasma solu

151 ate (eGFR) of 25-<60 mL/min per 1.73 m(2), a urine albumin-to-creatinine ratio (UACR) of >100-<=5000

152 in per 1.73 m(2) of body surface area, and a urine albumin-to-creatinine ratio (UACR) of 300-5000 mg/

153 to less than 60 mL/min/1.73 m2, doubling of urine albumin-to-creatinine ratio (UACR) to 30 mg/g or g

154 Albuminuria, routinely assessed as spot urine albumin-to-creatinine ratio (UACR), indicates stru

155 Finerenone also lowers the urine albumin-to-creatinine ratio (UACR).

156 rate clearance; albuminuria was estimated by urine albumin-to-creatinine ratio (UACR); and M/I was es

157 etes and albuminuric chronic kidney disease (urine albumin-to-creatinine ratio 30 to <300 mg/g and es

158 Eligible patients had a urine albumin-to-creatinine ratio 30 to 5,000 mg/g, an e

159 l included patients with type 2 diabetes and urine albumin-to-creatinine ratio 30 to 5000 mg/g and an

160 l included patients with type 2 diabetes and urine albumin-to-creatinine ratio 30 to 5000 mg/g and an

161 n rate 25 to 90 mL per min per 1.73 m(2), or urine albumin-to-creatinine ratio 300 to 5000 mg/g and e

162 tion 11 years, and GFR 153 mL/min and median urine albumin-to-creatinine ratio 36 mg/g), 69 progresse

163 ria; 60 had historic or current albuminuria (urine albumin-to-creatinine ratio [UACR] >=30 mg/g]), an

164 iltration rate [eGFR] >60 ml/min/1.73 m2 and urine albumin-to-creatinine ratio [uACR] <3 mg/mmol) at

165 y of type 2 diabetes, increased albuminuria (urine albumin-to-creatinine ratio [UACR] 30-3500 mg/g),

166 ssociations between urine albumin excretion (urine albumin-to-creatinine ratio [UACR]) and genomic re

167 ) study for the association between baseline urine albumin-to-creatinine ratio and estimated GFR (eGF

168 o had been assessed in 2006 to 2010 with the urine albumin-to-creatinine ratio and estimated glomerul

169 s when clinically indicated for measurement (urine albumin-to-creatinine ratio and hemoglobin A1c) or

170 rt failure) and include optional predictors (urine albumin-to-creatinine ratio and hemoglobin A1c), a

171 used parameters (glomerular filtration rate, urine albumin-to-creatinine ratio and urine protein-to-c

172 sistent for a prespecified baseline eGFR and urine albumin-to-creatinine ratio categories (P(interact

173 Compared with placebo, the urine albumin-to-creatinine ratio decreased by 34.0% (95

174 Effects on urine albumin-to-creatinine ratio did not differ between

175 The urine albumin-to-creatinine ratio genome-wide associatio

176 .6 to 3.0), and 4.8 (95% CI, 3.2 to 7.2) for urine albumin-to-creatinine ratio groups of 11 to 29 mg/

177 for estimated glomerular filtration rate and urine albumin-to-creatinine ratio in up to 12 207 Hispan

178 ml/min per 100 g body wt, P = 0.02), and the urine albumin-to-creatinine ratio increased markedly (co

179 imated glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio into low-, moderate-,

180 mated glomerular filtration rate categories, urine albumin-to-creatinine ratio levels, and KDIGO risk

181 Microalbuminuria was defined as urine albumin-to-creatinine ratio of 30 mg/g or more or

182 outcomes in patients with type 2 diabetes, a urine albumin-to-creatinine ratio of 30-5000 mg/g, an es

183 R 43 (SD 11) ml/min per 1.73 m(2) and median urine albumin-to-creatinine ratio of 362 mg/g (interquar

184 nt signs of kidney damage, such as increased urine albumin-to-creatinine ratio or a GFR below the thr

185 344, P=9.3x10(-11)) and validated 8 loci for urine albumin-to-creatinine ratio previously identified

186 eatment effect for death due to any cause by urine albumin-to-creatinine ratio was .01 [<300 mg/g HR

187 ion rate was 42.3 ml/min/1.73 m2, and median urine albumin-to-creatinine ratio was 3.4 mg/mmol.

188 Calibration improved significantly when the urine albumin-to-creatinine ratio was added to the base

189 kidney measures (creat-eGFR, cysC-eGFR, and urine albumin-to-creatinine ratio) led to significant im

190 Albuminuria (urine albumin-to-creatinine ratio) was measured in spot

191 Serum creatinine, serum albumin, the urine albumin-to-creatinine ratio, Charlson comorbidity

192 sted models for demographics, baseline eGFR, urine albumin-to-creatinine ratio, comorbidity, and meas

193 acute eGFR decline included higher baseline urine albumin-to-creatinine ratio, eGFR, systolic blood

194 was small but statistically significant when urine albumin-to-creatinine ratio, hemoglobin A1c, and s

195 , human immunodeficiency virus (HIV) status, urine albumin-to-creatinine ratio, hemoglobin, and lipid

196 tion group had higher hemoglobin A1c, higher urine albumin-to-creatinine ratio, increased glomerular

197 as the base model to which we added eGFR and urine albumin-to-creatinine ratio.

198 ositive association of lymphocyte count with urine albumin-to-creatinine ratio.

199 dex, geographic region, and higher levels of urine albumin-to-creatinine ratio.

200 e, estimated glomerular filtration rate, and urine albumin-to-creatinine ratio.

201 ant changes in VO2 peak, kidney function, or urine albumin-to-creatinine ratio.

202 not differ between groups when stratified by urine albumin-to-creatinine ratio.

203 hics, cardiovascular risk factors, eGFR, and urine albumin-to-creatinine ratio.

204 megalin, which inversely correlated with the urine albumin-to-creatinine ratio.

205 Using participants with urine albumin-to-creatinine ratios <10 mg/g as a referen

206 an unbiased genome-wide association scan of urine albumin-to-creatinine ratios.

207 Tirzepatide treatment was associated with urine albumin-to-creatinine reduction after 24 weeks, wh

208 We obtained blood and urine albumin, urea, creatinine, electrolytes, A1c, and

209 Comparison of urine albumin within 6 hrs of intensive care unit (ICU)